Amit Indubhushan Bakshi's most recent trade in Eris Lifesciences Ltd. was a Acquisition of 11,750 Equity Shares done at an average price of Rs. 615.0 . Disclosure was reported to the exchange on Feb. 6, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Amit Indubhushan Bakshi in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eris Lifesciences | Amit Indubhushan Bakshi | Promoter & Director | Acquisition | 06 Feb 2023 | 11,750 | 55,535,144 (40.84%) | 0.01% | 615.0 | 7,226,836 | 02 Feb 2023 03 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
Eris Lifesciences | Amit Indubhushan Bakshi | Promoter & Director | Acquisition | 23 Jan 2023 | 203,000 | 55,523,394 (40.82%) | 0.15% | 630 | 127,890,000 | 20 Jan 2023 20 Jan 2023 |
Insider Trading | Equity Shares | Market Purchase |
Eris Lifesciences | Amit Indubhushan Bakshi | Promoter & Director | Acquisition | 15 Dec 2022 | 396,262 | 55,320,394 (40.68%) | 0.29% | 663 | 262,721,706 | 14 Dec 2022 14 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
Eris Lifesciences | Amit Indubhushan Bakshi | Promoter & Director | Acquisition | 08 Dec 2022 | 165,000 | 54,924,132 (40.39%) | 0.12% | 660.7 | 109,015,829 | 06 Dec 2022 07 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
Eris Lifesciences | Amit Indubhushan Bakshi | Promoter & Director | Acquisition | 25 Aug 2021 | 34,534 | 54,759,132 (40.30%) | 0.03% | 728.2 | 25,148,014 | 20 Aug 2021 24 Aug 2021 |
Insider Trading | Equity Shares | Market Purchase |
Eris Lifesciences | Amit Indubhushan Bakshi | Promoter & Director | Acquisition | 19 Aug 2021 | 26,175 | 54,724,598 (40.28%) | 0.02% | 725.4 | 18,987,949 | 16 Aug 2021 18 Aug 2021 |
Insider Trading | Equity Shares | Market Purchase |